Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy
Condition: Hemophilic Arthropathy Interventions: Drug: TRM-201 (Rofecoxib); Drug: Placebo Sponsor: Tremeau Pharmceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2020 Category: Research Source Type: clinical trials
FDA Grants Orphan Drug Designation for TRM-201 (rofecoxib) for the Treatment of Hemophilic Arthropathy
CAMBRIDGE, Mass.--(BUSINESS WIRE) November 21, 2017 --Tremeau Pharmaceuticals, Inc., a new pharmaceutical company focused on providing non-opioid pain treatments for rare diseases, announced today that the U.S. Food and Drug Administration (FDA) has... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 21, 2017 Category: Pharmaceuticals Source Type: clinical trials
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)
Condition: Postoperative PainInterventions: Drug: MK0966, rofecoxib; Drug: Comparator: oxycodone and acetaminophenSponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2004 Category: Research Source Type: clinical trials
